Table 3.
a. Matrix effect on cediranib (Mean ± SD) | ||
ng/mL | Plasma | Brain Homogenate |
10 | −39.1% ± 4.2% | −35.6% ± 4.9% |
100 | −38.1% ± 2.0% | −46.8% ± 0.8% |
1000 | −48.6% ± 1.3% | −53.0% ± 1.4% |
b. Matrix effect on AG1478 (Mean ± SD) | ||
ng/mL | Plasma | Brain Homogenate |
40 | −52.6% ± 8.5% | −44.8% ± 4.1% |